Ascentawits
Shenzhen
About Ascentawits
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs. The company utilizes specific tumor micro-environments to carry out independent innovative drug designs and screening for the development of new anti-tumor drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $29.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2021)
- Website: ascentawits.com
- Phone: 0755-27888161
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Product Research
Canonical: https://fsome.com/organization/ascentawits-133835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.